Contrive Datum Insights_Logo.jpg
Digital Polymerase Chain Reaction (dPCR) Market to Reach Value of US$ 1,305.3 Million by 2030, And Rise At A CAGR of 8.6%, Contrive Datum Insights
January 11, 2023 10:29 ET | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The Global Digital Polymerase Chain Reaction (dPCR) Market Was Valued At USD 508.82 Million In 2021 And Is Projected To Reach USD 1,305.3 Million By...
PRPO logo.png
Precipio Announces First US Government Customer for ICE COLD-PCR™ Mutation Enrichment Technology
January 10, 2019 07:45 ET | Precipio, Inc.
NEW HAVEN, Conn., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has been approved by the United States Department of...
PRPO logo.png
Precipio Enters India Liquid Biopsy Market with Adoption by Leading Laboratory
March 26, 2018 07:38 ET | Precipio, Inc.
NEW HAVEN, Conn., March 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostic company Precipio, Inc. (NASDAQ:PRPO), today announced a laboratory services agreement with CORE Diagnostics to offer ICE...
Gary Pestano chair qPCR Congress talk
Biodesix Leaders Share Commercial and Pipeline Updates at Annual qPCR and dPCR Congress
December 05, 2017 06:00 ET | Biodesix, Inc.
BOULDER, Colo., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Biodesix provided updates and data related to the company’s on-market and in-development liquid biopsy tests at the 2017 qPCR & Digital PCR...